FDx Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,626
| Closed | -$254K | – | 813 |
|
|
2020
Q4 | $254K | Buy |
+1,626
| New | +$254K | 0.01% | 619 |
|
|
2020
Q2 | – | Sell |
-3,055
| Closed | -$274K | – | 637 |
|
|
2020
Q1 | $274K | Buy |
3,055
+1,048
| +52% | +$94K | 0.02% | 406 |
|
|
2019
Q4 | $217K | Buy |
+2,007
| New | +$217K | 0.01% | 572 |
|
|
2018
Q4 | – | Sell |
-1,623
| Closed | -$226K | – | 866 |
|
|
2018
Q3 | $226K | Sell |
1,623
-792
| -33% | -$110K | 0.01% | 795 |
|
|
2018
Q2 | $300K | Sell |
2,415
-7,663
| -76% | -$952K | 0.01% | 726 |
|
|
2018
Q1 | $1.12M | Sell |
10,078
-569
| -5% | -$63.4K | 0.03% | 468 |
|
|
2017
Q4 | $1.27M | Buy |
10,647
+33
| +0.3% | +$3.95K | 0.03% | 467 |
|
|
2017
Q3 | $1.49M | Sell |
10,614
-668
| -6% | -$93.7K | 0.04% | 412 |
|
|
2017
Q2 | $1.37M | Buy |
11,282
+366
| +3% | +$44.5K | 0.04% | 430 |
|
|
2017
Q1 | $1.32M | Sell |
10,916
-4,720
| -30% | -$572K | 0.04% | 427 |
|
|
2016
Q4 | $1.91M | Sell |
15,636
-582
| -4% | -$71.2K | 0.06% | 294 |
|
|
2016
Q3 | $1.99M | Buy |
16,218
+4,322
| +36% | +$530K | 0.08% | 211 |
|
|
2016
Q2 | $1.39M | Buy |
11,896
+1,994
| +20% | +$233K | 0.06% | 276 |
|
|
2016
Q1 | $1.38M | Sell |
9,902
-621
| -6% | -$86.5K | 0.06% | 278 |
|
|
2015
Q4 | $2.01M | Buy |
10,523
+2,574
| +32% | +$491K | 0.09% | 187 |
|
|
2015
Q3 | $1.24M | Buy |
7,949
+1,432
| +22% | +$224K | 0.11% | 195 |
|
|
2015
Q2 | $1.18M | Buy |
6,517
+4,317
| +196% | +$780K | 0.06% | 291 |
|
|
2015
Q1 | $373K | Buy |
2,200
+41
| +2% | +$6.95K | 0.01% | 1109 |
|
|
2014
Q4 | $399K | Buy |
+2,159
| New | +$399K | 0.02% | 626 |
|